Birznieks Gunther

Avg. Two Year Performance

No purchase track record

4% Avg. Sale Return

2% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	3%	9%	9%	4%	4%
Sale Success Rate	5 of 7	4 of 7	3 of 7	2 of 7	1 of 7

Vanda Pharmaceuticals, Inc.

Drugs » Biotechnology

SVP, Business Development:

Holdings: 313.57K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--